Showing results (31-40 of 85) with videos related to
Sort By:
Pageof 9
Journal of Viral Hepatitis|August 7, 2024
Assessment of HBV variants and novel viral and immune biomarkers in chronic hepatitis B patients with metabolic dysfunction associated steatotic liver diseaseNishi H Patel, Aaron Lucko, Alicia Vachon, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 2022
Brief Report: Effect of Antiretroviral Switch From Tenofovir Disoproxil fumarate to Tenofovir Alafenamide on Alanine Aminotransferase, Lipid Profiles, and Renal Function in HIV/HBV-Coinfected Individuals in a Nationwide Canadian StudyArif Sarowar, Carla S Coffin, Scott Fung, et al.Journal of Viral Hepatitis|July 27, 2018
Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma riskMaryam Darvishian, Naveed Z Janjua, Mei Chong, et al.NPJ Vaccines|January 12, 2021
Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)Shivali S Joshi, Rachelle P Davis, Mang M Ma, et al.Journal of the Canadian Association of Gastroenterology|March 1, 2021
Improvement of Endoscopic Reports with Implementation of a Dictation TemplateNatasha Harris, Jennifer Telford, Jordan Yonge, et al.Journal of the Canadian Association of Gastroenterology|April 25, 2020
Validation of the St. Paul's Endoscopy Comfort Scale (SPECS) for ColonoscopyJennifer Telford, Iran Tavakoli, Oliver Takach, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 7, 2021
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian RegistryFernanda Q Onofrio, Curtis Cooper, Sergio M Borgia, et al.Hepatology (Baltimore, Md.)|January 30, 2013
JUMP-C: a randomized trial of mericitabine plus pegylated interferon alpha-2a/ribavirin for 24 weeks in treatment-naïve HCV genotype 1/4 patientsPaul J Pockros, Donald Jensen, Naoky Tsai, et al.Hepatology Communications|April 13, 2019
Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist TherapyNaveed Z Janjua, Maryam Darvishian, Stanley Wong, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 29, 2025
HBV Care Cascade in Rwanda: A Population-based Study From 2016-2023Jean Damascene Makuza, Dahn Jeong, Michael Law, et al.Pageof 9